NHNKY
Price
$12.54
Change
-$0.01 (-0.08%)
Updated
Jul 25 closing price
Capitalization
2.23B
QGEN
Price
$51.79
Change
+$0.56 (+1.09%)
Updated
Jul 25 closing price
Capitalization
9.52B
10 days until earnings call
Interact to see
Advertisement

NHNKY vs QGEN

Header iconNHNKY vs QGEN Comparison
Open Charts NHNKY vs QGENBanner chart's image
Nihon Kohden
Price$12.54
Change-$0.01 (-0.08%)
Volume$1.79K
Capitalization2.23B
Qiagen
Price$51.79
Change+$0.56 (+1.09%)
Volume$1.29M
Capitalization9.52B
NHNKY vs QGEN Comparison Chart in %
Loading...
NHNKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NHNKY vs. QGEN commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NHNKY is a Hold and QGEN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (NHNKY: $12.54 vs. QGEN: $51.79)
Brand notoriety: NHNKY and QGEN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NHNKY: 35% vs. QGEN: 92%
Market capitalization -- NHNKY: $2.23B vs. QGEN: $9.52B
NHNKY [@Medical Specialties] is valued at $2.23B. QGEN’s [@Medical Specialties] market capitalization is $9.52B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NHNKY’s FA Score shows that 2 FA rating(s) are green whileQGEN’s FA Score has 1 green FA rating(s).

  • NHNKY’s FA Score: 2 green, 3 red.
  • QGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, both NHNKY and QGEN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NHNKY’s TA Score shows that 4 TA indicator(s) are bullish while QGEN’s TA Score has 4 bullish TA indicator(s).

  • NHNKY’s TA Score: 4 bullish, 3 bearish.
  • QGEN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NHNKY is a better buy in the short-term than QGEN.

Price Growth

NHNKY (@Medical Specialties) experienced а +15.05% price change this week, while QGEN (@Medical Specialties) price change was +7.09% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was +5.16%, and the average quarterly price growth was -1.87%.

Reported Earning Dates

QGEN is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QGEN($9.52B) has a higher market cap than NHNKY($2.23B). QGEN has higher P/E ratio than NHNKY: QGEN (27.85) vs NHNKY (18.12). QGEN YTD gains are higher at: 20.284 vs. NHNKY (-12.613). NHNKY has higher annual earnings (EBITDA): 27.2B vs. QGEN (689M). NHNKY has more cash in the bank: 43.7B vs. QGEN (1.06B). NHNKY has less debt than QGEN: NHNKY (433M) vs QGEN (1.53B). NHNKY has higher revenues than QGEN: NHNKY (202B) vs QGEN (1.97B).
NHNKYQGENNHNKY / QGEN
Capitalization2.23B9.52B23%
EBITDA27.2B689M3,948%
Gain YTD-12.61320.284-62%
P/E Ratio18.1227.8565%
Revenue202B1.97B10,280%
Total Cash43.7B1.06B4,130%
Total Debt433M1.53B28%
FUNDAMENTALS RATINGS
NHNKY vs QGEN: Fundamental Ratings
NHNKY
QGEN
OUTLOOK RATING
1..100
6121
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
82
Overvalued
PROFIT vs RISK RATING
1..100
10061
SMR RATING
1..100
1787
PRICE GROWTH RATING
1..100
5644
P/E GROWTH RATING
1..100
673
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NHNKY's Valuation (9) in the null industry is significantly better than the same rating for QGEN (82) in the Medical Specialties industry. This means that NHNKY’s stock grew significantly faster than QGEN’s over the last 12 months.

QGEN's Profit vs Risk Rating (61) in the Medical Specialties industry is somewhat better than the same rating for NHNKY (100) in the null industry. This means that QGEN’s stock grew somewhat faster than NHNKY’s over the last 12 months.

NHNKY's SMR Rating (17) in the null industry is significantly better than the same rating for QGEN (87) in the Medical Specialties industry. This means that NHNKY’s stock grew significantly faster than QGEN’s over the last 12 months.

QGEN's Price Growth Rating (44) in the Medical Specialties industry is in the same range as NHNKY (56) in the null industry. This means that QGEN’s stock grew similarly to NHNKY’s over the last 12 months.

QGEN's P/E Growth Rating (3) in the Medical Specialties industry is somewhat better than the same rating for NHNKY (67) in the null industry. This means that QGEN’s stock grew somewhat faster than NHNKY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NHNKYQGEN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
44%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
57%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
55%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
54%
Advances
ODDS (%)
Bullish Trend 17 days ago
58%
Bullish Trend 2 days ago
57%
Declines
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 20 days ago
50%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
56%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
NHNKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TCPB50.660.10
+0.20%
Thrivent Core Plus Bond ETF
ESIX29.97N/A
N/A
SPDR S&P SmallCap 600 ESG ETF
CAF14.40-0.03
-0.21%
Morgan Stanley China A Share Fund
SPWO24.95-0.12
-0.49%
SP Funds S&P World ETF
YINN46.96-0.98
-2.04%
Direxion Daily FTSE China Bull 3X ETF

QGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, QGEN has been loosely correlated with A. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if QGEN jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QGEN
1D Price
Change %
QGEN100%
+1.09%
A - QGEN
60%
Loosely correlated
-0.14%
RVTY - QGEN
57%
Loosely correlated
+1.67%
BRKR - QGEN
56%
Loosely correlated
+3.68%
TMO - QGEN
55%
Loosely correlated
+0.69%
DHR - QGEN
55%
Loosely correlated
+1.32%
More